Daniel T. McKillop
Partner
201-896-7115 dmckillop@sh-law.comAuthor: Daniel T. McKillop|May 7, 2018
New Jersey is working toward legalization of recreational marijuana and the State is actively expanding its medical marijuana program. Licensing of marijuana retailers and additional medical dispensaries will be critical components of these efforts. Two bills currently in committee give indications of how New Jersey plans to proceed with such licensing.
As discussed in greater detail in a prior article, Gov. Murphy issued an executive order shortly after his inauguration directing the New Jersey Department of Health (DOH) to conduct a comprehensive review of the Medical Marijuana Program (MMP). The DOH recently issued a report setting forth more than 20 recommendations. Of these, several have been implemented with immediate effect, including the addition of five new categories of medical conditions (anxiety, migraines, Tourette’s syndrome, chronic pain related to musculoskeletal disorders, and chronic visceral pain) to the list of qualifying conditions eligible for marijuana prescription, reduction of fees for patients, and allowing existing medical Alternative Treatment Centers (ATCs) to apply to open satellite locations. Other recommendations by the DOH pertain to regulatory changes that will go through the rulemaking process and proposals that require legislative approval.
If you are interested in learning more about Assembly Bill No. 3740 and No. 3437, which are relevant to the expansion of medical marijuana in New Jersey, a PDF containing specific details regarding both bills can be found by clicking (Information on proposed Medical Marijuana bills in New Jersey). An additional PDF which includes a summary of the bills can be found by clicking (Summary of the proposed Medical Marijuana bills in New Jersey).
Opportunities to apply for recreational marijuana retailer licenses and medical marijuana dispensary licenses are on the horizon. The Scarinci Hollenbeck Cannabis Law Practice group will be continuously tracking developments and all relevant. We encourage current and prospective members of the New Jersey cannabis industry to check back regularly for updates.
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
Partner
201-896-7115 dmckillop@sh-law.comNew Jersey is working toward legalization of recreational marijuana and the State is actively expanding its medical marijuana program. Licensing of marijuana retailers and additional medical dispensaries will be critical components of these efforts. Two bills currently in committee give indications of how New Jersey plans to proceed with such licensing.
As discussed in greater detail in a prior article, Gov. Murphy issued an executive order shortly after his inauguration directing the New Jersey Department of Health (DOH) to conduct a comprehensive review of the Medical Marijuana Program (MMP). The DOH recently issued a report setting forth more than 20 recommendations. Of these, several have been implemented with immediate effect, including the addition of five new categories of medical conditions (anxiety, migraines, Tourette’s syndrome, chronic pain related to musculoskeletal disorders, and chronic visceral pain) to the list of qualifying conditions eligible for marijuana prescription, reduction of fees for patients, and allowing existing medical Alternative Treatment Centers (ATCs) to apply to open satellite locations. Other recommendations by the DOH pertain to regulatory changes that will go through the rulemaking process and proposals that require legislative approval.
If you are interested in learning more about Assembly Bill No. 3740 and No. 3437, which are relevant to the expansion of medical marijuana in New Jersey, a PDF containing specific details regarding both bills can be found by clicking (Information on proposed Medical Marijuana bills in New Jersey). An additional PDF which includes a summary of the bills can be found by clicking (Summary of the proposed Medical Marijuana bills in New Jersey).
Opportunities to apply for recreational marijuana retailer licenses and medical marijuana dispensary licenses are on the horizon. The Scarinci Hollenbeck Cannabis Law Practice group will be continuously tracking developments and all relevant. We encourage current and prospective members of the New Jersey cannabis industry to check back regularly for updates.
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.